Alerta Alcohol. Web-based Computer-tailored Intervention for Binge-drinking Prevention in Spanish Adolescents
Launched by UNIVERSITY OF SEVILLE · Sep 19, 2017
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Binge-drinking in adolescents is a highly prevalent healthcare problem that associates physical and mental health complications and community implications.
The "Alerta Alcohol" program is based on the I-Change Model. Focus and Delphi groups are used to obtain further information on items included in the program. A pilot study is conducted to identify strengths and weaknesses. A Cluster Randomized Controlled Trial is carried out. The schools from Andalusia are randomized either to the experimental or the control condition (EC and CC). The EC receives the Alerta Alcohol intervention, which c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Students aged 16 to 18 years.
- • Enrolled in Andalusian public high schools.
- • Schools belonging to provincial capitals.
- • Access to the Internet at the school and an equipped ICT room.
- Exclusion Criteria:
- • Language barriers.
- • Previous participation in prevention programs for binge drinking.
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sevilla, , Spain
Patients applied
Trial Officials
Marta Lima Serrano, PhD
Study Director
University of Seville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials